Inflammatory and Oxidative Stress Biomarkers in the Elderly, the Birjand Longitudinal Aging Study

Moshtagh, Mozhgan; Moodi, Mitra; Moezi, Seyyed Ali; Sharifi, Farshad; Khazdair, Mohammad Reza

doi:https://doi.org/10.1155/2023/4683542

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Special Issue

Autophagy, Oxidative Stress and their Interactions in Senescence

View this Special Issue

Research Article | Open Access

Volume 2023 | Article ID 4683542 | https://doi.org/10.1155/2023/4683542

Inflammatory and Oxidative Stress Biomarkers in the Elderly, the Birjand Longitudinal Aging Study

Mozhgan Moshtagh,¹Mitra Moodi,²Seyyed Ali Moezi,³Farshad Sharifi,⁴and Mohammad Reza Khazdair³

Academic Editor: Ken-ichi Aihara

Received05 Jul 2022

Revised24 Oct 2022

Accepted28 Jan 2023

Published21 Feb 2023

Abstract

Cigarette smoking is a significant risk factor for chronic and atherosclerotic vascular disease that causes preventable considerable morbidity and mortality worldwide. This study is aimed at comparing inflammation and the levels of oxidative stress biomarkers in elderly subjects. The authors recruited the participants (1281 older adults) from the Birjand Longitudinal of Aging study. They measured oxidative stress and inflammatory biomarkers serum levels in the 101 cigarettes and 1180 nonsmokers. The mean age of smokers was years, and most were male. The most percentage of male cigarette smokers have lower body mass index (BMI) (≤19 kg/m²). Females have higher BMI categories than males (). The percentage of diseases and defects was different between cigarette and non-cigarette smoker adults ( to ). The total white blood cells, neutrophils, and eosinophils were significantly higher in cigarettes compared to non-cigarette smokers (). Besides, cigarette consumers’ percentage of hemoglobin and hematocrit compared to other aged people was significantly different (). However, biomarkers of oxidative stress and antioxidant levels were not significant differences between the two senior groups. Cigarette smoking in older adults was associated with increased inflammatory biomarkers and cells, but it did not find a significant difference in oxidative stress markers. Longitudinal prospective studies may help illuminate the mechanisms inducing oxidative stress and inflammation due to cigarette smoking in each gender.

1. Introduction

According to free radicals theory, the aging process results from cellular damages caused by metabolism, mainly mitochondrial respiration [1, 2].

Decreasing muscle mass versus increasing fat tissue can be considered chronic low-grade inflammatory conditioning in aging. It can lead to high levels of reactive oxygen species (ROS) and changing inflammatory adipocytokines and antioxidative enzymes [3, 4]. Although normal levels of ROS are essential for various cellular mechanisms [1], insufficiency of the antioxidants system and inability to detoxify the increased ROS would lead to oxidative stress (OS), or a state of imbalance between the production and regulation of ROS [5–7].

Oxidative stress in old age may harm cellular pieces of the membrane leading to loss of function and reduced metabolic efficiency [5, 6]. In this regard, OS might be the primary contributor to the formation of cardiovascular disorders owing to endothelial dysfunction through increased inflammatory and reduced anti-inflammatory cytokines [3]. Hence, inactivating nitric oxide within endothelial cells by OS may impair lipids metabolism, insulin regulation, and blood flow [3].

Genetic and social factors may harm the accumulation of OS, for example, UV light, X-ray, air pollutants, certain drugs, and tobacco smoking [1, 7]. OS is significantly an identified risk factor in most annual mortalities and fatal diseases such as cancer, cardiovascular and cerebral events due to carcinogenic, proinflammatory, and prooxidative effects [8, 9].

Smoking has been recognized as the most significant risk factor for cardiovascular disease due to widespread use in low-middle countries [10]. Existed evidence has demonstrated that tobacco smoking has a higher prevalence rate in the Asian old population, and men consume more (22.5%) compared to women (8.7%) [11]. Another study on smoking prevalence among Iranians has found cigarette consumption of nearly 13.5% for current older smoker men and 16% among past users [12].

High rates of oxidants and toxic substances in cigarettes damage airway epithelial cells, lipids, and DNA, stimulating oxidative stress, systemic inflammation, and increasing leukocytes [13]. In addition, research has found that tobacco smoking is associated with changes in inflammatory mediators, CRP, fibrinogen level, and type or number of lymphocytes identified as predictors of cardiovascular disorders [13, 14]. According to studies findings, the surge of inflammatory markers like interleukin- (IL-) 6 and C-reactive protein (CRP) is related to the number of cigarettes consumed in the life period [15, 16]. Thus, serum concentrations, accumulation, and pathophysiological effects of inflammatory markers should be higher in heavy smokers’ older adults than others. Although evidence has demonstrated some atherogenic properties of tobacco smoking, probably owing to OS and inflammation, it is not clear that OS is primarily responsible for vascular dysfunction and causes inflammation or vice versa. Limitations of previous studies, including not considering the underlying characteristics of participants, persuaded researchers to perform a population-based investigation on the aged population [17, 18]. This study aimed at studying oxidative stress and inflammation changes in elderly cigarette and nonsmoker. This data can help understand the effects of cigarette consumption on the reaction of inflammatory/immune systems in old age.

2. Materials and Methods

2.1. Study Design and Participants

The years who were residents in urban and rural regions of Birjand County were invited to participate in the Birjand Longitudinal of Aging study. The participants were selected using multistage stratified cluster sampling. The city’s postal areas identified 70 clusters. In each group, 20 subjects (equal numbers of males and females) were assigned [19].

Through a short interview, an expert nurse collected demographic information such as sex, age, and history of cigarette smoking. Current smokers identified with a cigarette smoking index of ≥10 pack-years (calculated by multiplying the number of cigarettes per day by the number of years spent smoking, divided by 20 cigarettes in one pack). The anthropometric measurements were also performed, and blood samples were obtained [19]. Exclusion criteria included confirmed asthma, COPD, and upper/lower respiratory tract infection in the preceding four weeks. Furthermore, the aged were completely bedridden or unable to communicate owing to severe cognitive impairment and Alzheimer’s disease, and those with very short life expectancy (less than six months). The Institutional and Science committees ethically confirmed the study, and all participants gave written informed consent.

The serum concentration levels of oxidative stress and inflammatory markers from 101 cigarettes and 1180 non-cigarette smokers included as a reference control group were analyzed.

2.2. Serum Sample

Blood samples were drained from the cubital vein in the morning after fasting for 12 hours and collected into blood collection tubes (ORUM TADJHIZ CO, Iran, ISO 9001& 13438) without an anticoagulant using a clot separator gel. The serum was separated after 30 minutes by centrifugation at 1600g for 10 minutes, aliquoted, and stored at -80°C until use.

2.3. Hematologic Analysis

Hematologic indexes were analyzed by an automated hematology analyzer (SysmexKX-21 (Sysmex Corporation Kobe, Japan)). Those indexes include cell blood count (CBC), hemoglobin (Hb), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC).

2.4. Cytokine Analysis

According to the manufacturer’s instructions, serum cytokine (hsCRP) profiling was performed, using Pars Azmun, Prestige 24i analyzer (Tokyo, Japan) using the serum samples without dilution. Serum cytokine levels were expressed as the median (range) in pg/ml.

2.5. Oxidative Stress Measurement

Evaluating oxidant stress was performed by determining the plasma concentration of markers such as porcine plasma protein hydrolysate (PPPH; radical scavenging activity (RSA) based on DPPH assay), thiol (total thiol groups based on Ellman assay), and thiobarbituric acid reactive substances (TBARS; lipid peroxidation based on thiobarbituric acid reactive substances). Furthermore, the researchers measured ferric reducing antioxidant power (FRAP) to investigate the antioxidant potential of serum levels (total antioxidant capacity (TAC) based on FRAP assay) (Table 1).

2.6. Ethical Approval

All the participants signed the informed consent after reading or explaining the content of the informed consent. The biobanking of the blood sample and how the researchers will be able to use it for future research were described in the consent form. The ethical research committee simultaneously approved the protocols of the current study of Endocrinology and Metabolism Research Institute (EMRI) of Tehran University of Medical Sciences (TUMS), (IR.TUMS.EMRI.REC.1396.00158) and the ethical committee of Birjand University of Medical Sciences (IR.BUMS.Rec.1397.282).

2.7. Statistical Analysis

Data were analyzed by the SPSS (v.22) software using the -test, Mann–Whitney, and Kolmogorov-Smirnov test. Demographic and clinical data were expressed as the mean (SD), and differences between the study groups were analyzed by -test (parametric data). Data for cytokine concentration levels were expressed as the median (interquartile range), and differences across the study groups were analyzed using Mann–Whitney and -test. was considered significant.

3. Results

A total of 1281 elderly were included in the current study. The mean age of cigarette and non-cigarette smokers was and years, respectively. Generally, the frequency of the male gender cigarette smokers was significantly more compared to the non-cigarettes smokers’ group () (Table 2). The most percentage of male cigarette smokers have lower body mass index (BMI) (≤19 kg/m²). Also, the most percentage of females have a higher BMI (≥23 kg/m²) compared to male adults ().

The history of diseases percentage in the total population and disease and defects history in both two groups of elderly cigarette and non-cigarette smokers are presented in Table 3. The rate of high blood pressure, diabetes, blood lipid profile, and osteoarthritis in non-cigarette smokers was significantly higher than in the smoker group ( to ). The percentage of prostate diseases in cigarette smokers was significantly higher compared to the non-cigarette group () (Table 3). The two study groups did not differ substantially concerning inflammatory and oxidative stress biomarkers (Table 4). Total white blood cells (WBC), neutrophils (Neut), and eosinophils (Eos) in cigarette smokers were significantly higher compared to the non-cigarette smoker’s group ( to ). The lymphocyte percentage (Lymph) was considerably lower in cigarette smokers () compared to the non-cigarette smoker group (Table 5).

HCT, MCV, MCH, and MCHC were significantly higher in cigarettes than the non-cigarette smoker’s group ( to ). On the contrary, hemoglobin (Hb) was substantially lower in cigarette smokers () compared to the elderly non-cigarette smokers (Table 5).

4. Discussion

This investigation analyzed the inflammatory and oxidative stress biomarkers levels in non-cigarettes smokers and older adults.

The present study showed that the percentage of high blood pressure, diabetes, blood lipid profile, and osteoarthritis was significantly higher in non-cigarettes smokers than the elderly cigarette smokers. Based on the gender of participants, female is the major of non-cigarette smokers. A previous study showed that healthy females’ lipid profile and blood pressure were significantly higher than healthy males [20]. Also, gender affects lipid parameters, independent of age, and menopausal status [21]. Presumably, these differences are due to the different levels of circulating sex hormones, specifically estrogens and androgens, in women versus men. It has been suggested that menopause may potentiate the age-related increase in systolic blood pressure, perhaps due to reduced arterial compliance.

The older age, male sex, diabetes, tobacco use, overweight, and obesity are independent predictors of coronary plaque and high-risk plaque in the population with a mean age of 53 years [22]. The prospective cohort study in Asia showed that secondhand smoke might raise the risk of ischemic heart disease (IHD) and the risk of incident cardiovascular disease (CVD) in middle-aged never-smoking women [23]. The study also showed that coffee consumption was associated with a low risk of all and non-Alzheimer’s dementia. In contrast, smoking was associated with a high risk of non-Alzheimer’s dementia in the general population with a median age of 58 years [24].

Furthermore, healthy lifestyles, including never vs. current smoking, leisure-time physical activity vs. none, and 7–9 hours vs. >9 hours of sleep, were individually associated with an 11%–25% reduced risk of Alzheimer’s disease and related dementias in patients’ years old [25]. These results suggest that maintaining a healthy lifestyle is associated with a lower risk of diseases among older people.

The results of the current study show the BMI scores of female elderly were higher compared to male cigarette smokers. It has been reported that the prevalence of obesity among older females was higher than among males (42.9% and 38.3%, respectively) [26]. The prevalence of obesity among the elderly was significantly higher, and females had more predilection for obesity than males [27]. In addition, the previous study indicated that older adult females were more obese than males, and current smokers were less [28], which supports the present study’s results.

The current study showed that 92% of smokers are males, and the percentage of prostate diseases was significantly higher in male cigarettes than in non-cigarette smokers. The possible relation between prostate cancer and cigarette smoking has been considered previously [29], which supported the current study results. Antioxidant parameter levels, including ferric reducing antioxidant power (FRAP), PPPH, and thiobarbituric acid reactive substances (TBARS), were decreased. Versus, the high-sensitivity C-reactive protein (hsCRP) was increased in cigarette smokers compared to the non-cigarette smoker subjects. Although these changes observed between the two groups were not significant, it may be due to the gender and small sample size of the cigarette smoker group. Based on the obtained data in the current study, BMI in female elderly was higher compared to male cigarette smokers. It has been reported that the macronutrients in the adipose tissues stimulated the release of inflammatory mediators such as TNF-α and IL-6 and reduced adiponectin production, predisposing to a proinflammatory state and oxidative stress [30]. Moreover, obesity was associated with an increase in the production of leptin as a proinflammatory and a reduction in adiponectin as an anti-inflammatory mediator [31]. Also, adipokines (adipocytokines) that are produced by the adipose tissue induce the production of reactive oxygen species (ROS), generating a process known as oxidative stress (OS). Obesity produces OS by mitochondrial and peroxisomal oxidation of fatty acids, which can produce ROS [32]. The results of these studies indicated that upon the increase of adipose tissue, the activity of antioxidant enzymes significantly diminished while OS and inflammatory mediators enhanced. These results indicated that although the levels of antioxidant parameters and inflammatory mediator increase in cigarette smokers, due to gender and obesity in non-cigarette smokers (female), these changes were not significant.

Exposure to tobacco promotes a more rapid decline in lung function raised oxidative stress and persistence of inflammation [33]. It has been reported that oxidative stress is generally higher in men than in premenopausal women. However, the biomarkers of oxidative stress and the risk of experiencing cardiovascular events increased in postmenopausal women [34]. Besides, different serum hydroperoxides (as the oxidative stress index) levels were observed in elderly subjects of both genders with or without coronary artery disease [35].

Our findings showed that cigarette smoking has adverse effects on hematological parameters, including white blood cell (WBC) count, Hb, HCT, MCV, MCH, and MCHC.

In our study, the number of leukocytes, hemoglobin, and hematocrit values was significantly higher in smokers than in nonsmokers. The study results revealed that the hematological parameters were significantly increased in smokers of both genders than in nonsmokers [36]. Lakshmi et al. also showed that the Hct and Hb levels were significantly higher in smokers [37], supporting the current study results. Cigarette smoking is associated with an increase in WBC count and Hb levels in total blood. Also, obesity and aging are inversely related to Hb levels in the blood [38]. An increase in hemoglobin concentration is believed to be mediated by carbon monoxide exposure, which suggests that an increase in hemoglobin level in the blood of smokers could be a compensatory mechanism.

MCV, MCH, and MCHC are the three leading red blood cell indices that help measure the red blood cells’ average size and hemoglobin composition. The larger MCV, MCH, and MCHC in smokers elder were observed compared to the nonsmoker subjects, which was confirmed by other studies [39, 40].

As gender (for example, differences in body mass index) could influence inflammatory markers status, our results may be affected. The significant difference in the percentage of inflammatory markers and hematocrit of cigarette consumers follows the evidence and is in line with other research and confirms our hypothesis. Many studies have reported an association between smoking and inflammatory or immune response [41, 42]. The cross-sectional design of the current research and a more significant number of older women than males were some of its limitations. On the other hand, the majority of smokers had male gender.

5. Conclusion

Cigarette smoking increases hematological and inflammatory parameters associated with a greater risk for various diseases. Cigarette smoking in older adults was associated with increased inflammatory biomarkers, but any significant difference was found in biomarkers of oxidative stress. The higher BMI and obesity were associated with increased production of oxidative stress and proinflammatory markers. Longitudinal prospective studies may help determine the causal pathways and mechanisms inducing oxidative stress and inflammation due to cigarette smoking in each gender.

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this article.

Acknowledgments

We thank the research council of Birjand University of Medical Sciences.

References

D. Gorni and A. Finco, “Oxidative stress in elderly population: a prevention screening study,” Aging Medicine, vol. 3, no. 3, pp. 205–213, 2020.
View at: Publisher Site | Google Scholar
D. Harman, “Free radical theory of aging: an update: increasing the functional life span,” Annals of the New York Academy of Sciences, vol. 1067, no. 1, pp. 10–21, 2006.
View at: Publisher Site | Google Scholar
H. M. Kelli, F. E. Corrigan, R. E. Heinl et al., “Relation of changes in body fat distribution to oxidative stress,” The American Journal of Cardiology, vol. 120, no. 12, pp. 2289–2293, 2017.
View at: Publisher Site | Google Scholar
A. Zembron-Lacny, W. Dziubek, E. Wolny-Rokicka, G. Dabrowska, and M. Wozniewski, “The relation of inflammaging with skeletal muscle properties in elderly men,” American Journal of Men's Health, vol. 13, no. 2, 2019.
View at: Publisher Site | Google Scholar
R. Carnevale, V. Cammisotto, F. Pagano, and C. Nocella, “Effects of smoking on oxidative stress and vascular function,” in Giuseppe La Torre. Smoking Prevention and Cessation, M. Rajer, Ed., pp. 25–47, Intech Open, United Kingdom, London, 2018.
View at: Publisher Site | Google Scholar
E. Eleutherio, A. . A. Brasil, M. B. França, D. S. G. de Almeida, G. B. Rona, and R. S. S. Magalhães, “Oxidative stress and aging: Learning from yeast lessons,” Fungal Biology, vol. 122, no. 6, pp. 514–525, 2018.
View at: Publisher Site | Google Scholar
N. T. Moldogazieva, I. M. Mokhosoev, T. I. Mel’nikova, Y. B. Porozov, and A. A. Terentiev, “Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases,” Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 3085756, 14 pages, 2019.
View at: Publisher Site | Google Scholar
X. Q. Lao, C. Q. Jiang, W. S. Zhang et al., “Smoking, smoking cessation and inflammatory markers in older Chinese men: the Guangzhou Biobank Cohort Study,” Atherosclerosis, vol. 203, no. 1, pp. 304–310, 2009.
View at: Publisher Site | Google Scholar
M. G. Ugur, R. Kutlu, and I. Kilinc, “The effects of smoking on vascular endothelial growth factor and inflammation markers: a case-control study,” The Clinical Respiratory Journal, vol. 12, no. 5, pp. 1912–1918, 2018.
View at: Publisher Site | Google Scholar
Y. Ruan, Y. Guo, Y. Zheng et al., “Cardiovascular disease (CVD) and associated risk factors among older adults in six low-and middle-income countries: results from SAGE Wave 1,” BMC Public Health, vol. 18, no. 1, p. 778, 2018.
View at: Publisher Site | Google Scholar
S. Sarkar, N. Chawla, and P. Dayal, “Smoking and tobacco use cessation in the elderly,” Journal of Geriatric Mental Health, vol. 7, no. 2, pp. 70–77, 2020.
View at: Publisher Site | Google Scholar
M. B. Mehboudi, I. Nabipour, K. Vahdat et al., “Inverse association between cigarette and water pipe smoking and hypertension in an elderly population in Iran: Bushehr elderly health programme,” Journal of Human Hypertension, vol. 31, no. 12, pp. 821–825, 2017.
View at: Publisher Site | Google Scholar
J. A. Sgambato, B. A. Jones, J. W. Caraway, and G. L. Prasad, “Inflammatory profile analysis reveals differences in cytokine expression between smokers, moist snuff users, and dual users compared to non-tobacco consumers,” Cytokine, vol. 107, pp. 43–51, 2018.
View at: Publisher Site | Google Scholar
A. M. Andersen, M.-K. Lei, S. R. H. Beach, R. A. Philibert, S. Sinha, and J. D. Colgan, “Cigarette and cannabis smoking effects on GPR15+ helper T cell levels in peripheral blood: relationships with epigenetic biomarkers,” Genes, vol. 11, no. 2, p. 149, 2020.
View at: Publisher Site | Google Scholar
M.-F. O’Connor, J. E. Bower, H. J. Cho et al., “To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers,” Brain, Behavior, and Immunity, vol. 23, no. 7, pp. 887–897, 2009.
View at: Publisher Site | Google Scholar
S. Mami, M. Eghbali, A. Khosravi et al., “Effect of opium addiction on T4, T3 and TSH in male and female rats,” Journal of Ilam University of Medical Sciences, vol. 20, no. 2, pp. 17–22, 2012.
View at: Google Scholar
M. H. Daloee, A. Avan, S. R. Mirhafez et al., “Impact of cigarette smoking on serum pro- and anti-inflammatory cytokines and growth factors,” American Journal of Men's Health, vol. 11, no. 4, pp. 1169–1173, 2017.
View at: Publisher Site | Google Scholar
L. K. Gossett, H. M. Johnson, M. E. Piper, M. C. Fiore, T. B. Baker, and J. H. Stein, “Smoking intensity and lipoprotein abnormalities in active smokers,” Journal of Clinical Lipidology, vol. 3, no. 6, pp. 372–378, 2009.
View at: Publisher Site | Google Scholar
M. Moodi, M. D. Firoozabadi, T. Kazemi et al., “Birjand longitudinal aging study (BLAS): the objectives, study protocol and design (wave I: baseline data gathering),” Journal of Diabetes & Metabolic Disorders, vol. 19, no. 1, pp. 551–559, 2020.
View at: Publisher Site | Google Scholar
S. S. Habib, M. Aslam, and W. Hameed, “Gender differences in lipids and lipoprotein (a) profiles in healthy individuals and patients with type 2 diabetes mellitus,” Pakistan Journal of Physiology, vol. 1, no. 1-2, 2005.
View at: Google Scholar
F. A. Trémollières, J.-M. Pouilles, C. Cauneille, and C. Ribot, “Coronary heart disease risk factors and menopause: a study in 1684 French women,” Atherosclerosis, vol. 142, no. 2, pp. 415–423, 1999.
View at: Publisher Site | Google Scholar
K. Nasir, M. Cainzos-Achirica, J. Valero-Elizondo et al., “Coronary Atherosclerosis in an Asymptomatic US Population: Miami Heart Study at Baptist Health South Florida,” JACC: Cardiovascular Imaging, vol. 15, no. 9, pp. 1604–1618, 2022.
View at: Google Scholar
Y. Kobayashi, K. Yamagishi, I. Muraki et al., “Secondhand smoke and the risk of incident cardiovascular disease among never- smoking women,” Preventive Medicine, vol. 162, article 107145, 2022.
View at: Publisher Site | Google Scholar
A. T. Nordestgaard, B. G. Nordestgaard, R. Frikke-Schmidt, I. Juul Rasmussen, and S. E. Bojesen, “Self-reported and genetically predicted coffee consumption and smoking in dementia: a Mendelian randomization study,” Atherosclerosis, vol. 348, pp. 36–43, 2022.
View at: Publisher Site | Google Scholar
J. J. Yang, L. M. Keohane, X.-F. Pan et al., “Association of healthy lifestyles with risk of Alzheimer disease and related dementias in low-income Black and White Americans,” Neurology, vol. 99, no. 9, pp. e944–e953, 2022.
View at: Publisher Site | Google Scholar
G. A. Shayo and F. M. Mugusi, “Prevalence of obesity and associated risk factors among adults in Kinondoni municipal district, Dar es Salaam Tanzania,” BMC Public Health, vol. 11, article 365, p. 1, 2011.
View at: Publisher Site | Google Scholar
S. Ariaratnam, W. S. Rodzlan Hasani, A. D. Krishnapillai et al., “Prevalence of obesity and its associated risk factors among the elderly in Malaysia: findings from The National Health and Morbidity Survey (NHMS) 2015,” PLoS One, vol. 15, no. 9, article e0238566, 2020.
View at: Publisher Site | Google Scholar
A. Singh, M. A. Peres, K. G. Peres, C. de Oliveira Bernardo, A. Xavier, and E. D’Orsi, “Gender differences in the association between tooth loss and obesity among older adults in Brazil,” Revista de Saúde Pública, vol. 49, p. 44, 2015.
View at: Publisher Site | Google Scholar
F. Levi and C. La Vecchia, “Tobacco smoking and prostate cancer: time for an appraisal,” Annals of Oncology, vol. 12, no. 6, pp. 733–738, 2001.
View at: Publisher Site | Google Scholar
M. S. Ellulu, I. Patimah, H. Khaza’ai, A. Rahmat, and Y. Abed, “Obesity and inflammation: the linking mechanism and the complications,” Archives of Medical Science, vol. 13, no. 4, pp. 851–863, 2017.
View at: Publisher Site | Google Scholar
F. P. de Heredia, S. Gómez-Martínez, and A. Marcos, “Obesity, inflammation and the immune system,” Proceedings of the Nutrition Society, vol. 71, no. 2, pp. 332–338, 2012.
View at: Publisher Site | Google Scholar
A. Fernández-Sánchez, E. Madrigal-Santillán, M. Bautista et al., “Inflammation, oxidative stress, and obesity,” International Journal of Molecular Sciences, vol. 12, no. 5, pp. 3117–3132, 2011.
View at: Publisher Site | Google Scholar
J. Donohue, “Ageing, Smoking and Oxidative Stress,” Thorax, vol. 61, no. 6, pp. 461-462, 2006.
View at: Publisher Site | Google Scholar
T. Ide, H. Tsutsui, N. Ohashi et al., “Greater oxidative stress in healthy young men compared with premenopausal women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 3, pp. 438–442, 2002.
View at: Publisher Site | Google Scholar
C. Vassalle, S. Maffei, C. Boni, and G. C. Zucchelli, “Gender-related differences in oxidative stress levels among elderly patients with coronary artery disease,” Fertility and Sterility, vol. 89, no. 3, pp. 608–613, 2008.
View at: Publisher Site | Google Scholar
M. Malenica, B. Prnjavorac, T. Bego et al., “Effect of cigarette smoking on haematological parameters in healthy population,” Medical Archives, vol. 71, no. 2, pp. 132–136, 2017.
View at: Publisher Site | Google Scholar
S. Anandha Lakshmi, G. K. P. Anandhi Lakshmanan, and A. Saravanan, “Effect of intensity of cigarette smoking on haematological and lipid parameters,” Journal of Clinical and Diagnostic Research, vol. 8, no. 7, article BC11, 2014.
View at: Google Scholar
T. Kawada, “Smoking-induced leukocytosis can persist after cessation of smoking,” Archives of Medical Research, vol. 35, no. 3, pp. 246–250, 2004.
View at: Publisher Site | Google Scholar
S. Brar, “Effect of smoking on red blood cells count, hemoglobin concentration and red cell indices,” PJMHS, vol. 8, no. 2, pp. 361–364, 2014.
View at: Google Scholar
C.-M. Kung, H.-L. Wang, and Z.-L. Tseng, “Cigarette smoking exacerbates health problems in young men,” Clinical and Investigative Medicine, vol. 31, no. 3, pp. E138–E149, 2008.
View at: Google Scholar
R. Falfán-Valencia, A. Ramírez-Venegas, J. L. Pérez Lara-Albisua et al., “Smoke exposure from chronic biomass burning induces distinct accumulative systemic inflammatory cytokine alterations compared to tobacco smoking in healthy women,” Cytokine, vol. 131, article 155089, 2020.
View at: Publisher Site | Google Scholar
F. Qiu, C.-L. Liang, H. Liu et al., “Impacts of cigarette smoking on immune responsiveness: up and down or upside down?” Oncotarget, vol. 8, no. 1, pp. 268–284, 2017.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Mozhgan Moshtagh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies